BR112018007545A2 - método para produzir flutemetamol. - Google Patents

método para produzir flutemetamol.

Info

Publication number
BR112018007545A2
BR112018007545A2 BR112018007545-0A BR112018007545A BR112018007545A2 BR 112018007545 A2 BR112018007545 A2 BR 112018007545A2 BR 112018007545 A BR112018007545 A BR 112018007545A BR 112018007545 A2 BR112018007545 A2 BR 112018007545A2
Authority
BR
Brazil
Prior art keywords
flutemetamol
general formula
above step
compound
predetermined general
Prior art date
Application number
BR112018007545-0A
Other languages
English (en)
Other versions
BR112018007545B1 (pt
Inventor
Okumura Yuki
Tonoya Gota
Matsunami Tomoyuki
Original Assignee
Ge Healthcare Limited
Nihon Medi-Physics Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Limited, Nihon Medi-Physics Co., Ltd filed Critical Ge Healthcare Limited
Publication of BR112018007545A2 publication Critical patent/BR112018007545A2/pt
Publication of BR112018007545B1 publication Critical patent/BR112018007545B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Saccharide Compounds (AREA)
  • Ink Jet (AREA)

Abstract

é provido um método para produzir flutemetamol incluindo as etapas de: reagir um composto precursor representado por uma fórmula geral predeterminada com um fluoreto radioativo para obter um composto de marcação com 18f representado por uma fórmula geral predeterminada; permitir que uma base forte atue sobre a mistura de reação da etapa acima contendo o composto precursor e o composto de marcação com 18f; após a etapa acima, purificar o composto de marcação com 18f usando um cartucho de extração em fase sólida de fase reversa; e remover um grupo protetor para obter [18f] flutemetamol.
BR112018007545-0A 2015-10-28 2016-10-17 Método para produzir [18f] flutemetamol BR112018007545B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015-211413 2015-10-28
JP2015211413A JP6485914B2 (ja) 2015-10-28 2015-10-28 フルテメタモルの製造方法
PCT/EP2016/074840 WO2017071980A1 (en) 2015-10-28 2016-10-17 Method for producing flutemetamol

Publications (2)

Publication Number Publication Date
BR112018007545A2 true BR112018007545A2 (pt) 2018-10-23
BR112018007545B1 BR112018007545B1 (pt) 2023-08-01

Family

ID=

Also Published As

Publication number Publication date
JP2017081847A (ja) 2017-05-18
CA2998985A1 (en) 2017-05-04
AU2016344537A1 (en) 2018-04-12
AU2016344537B2 (en) 2020-09-17
EP3368518B1 (en) 2019-12-04
JP6485914B2 (ja) 2019-03-20
CN108137520A (zh) 2018-06-08
RU2018113741A (ru) 2019-11-28
CN108137520B (zh) 2022-06-21
KR102668514B1 (ko) 2024-05-24
RU2733398C2 (ru) 2020-10-01
CA2998985C (en) 2023-10-31
US20190055207A1 (en) 2019-02-21
KR20180073581A (ko) 2018-07-02
HK1249098A1 (zh) 2018-10-26
ES2766474T3 (es) 2020-06-12
EP3368518A1 (en) 2018-09-05
WO2017071980A1 (en) 2017-05-04
IL258148B (en) 2020-08-31
IL258148A (en) 2018-05-31
MX2018005046A (es) 2018-06-13
RU2018113741A3 (pt) 2020-02-20
US10472338B2 (en) 2019-11-12

Similar Documents

Publication Publication Date Title
PE20180327A1 (es) Proceso para preparar 4-amino-piridazinas
CL2017003316A1 (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen.
AR108245A1 (es) Síntesis de indazoles
CU20170163A7 (es) Compuestos derivados de d-fenilalanina-n-sustituido con biciclos aromáticos, método de preparación de las mismas y composiciones farmacéuticas que los contienen
CR20170590A (es) Nuevos derivados hidroxiácido, un proceso para su preparación y composiciones farmacéuticas que los contienen
BR112014030365A2 (pt) síntese de composto antiviral
CO6700838A2 (es) Compuestos sustituidos de banzamida
BR112012033690A2 (pt) sais de cálcio de compostos como agentes anti-inflamatórios, imunomodulares e antitroliferativos
BR112017018305A2 (pt) desacetoxitubulisina h e análogos da mesma
BR112013016578A2 (pt) processo para preparar metilmercaptopropionaldeídeo
WO2016073425A3 (en) Method for preparing deuterated aromatic compounds
IN2014DN09394A (pt)
AR109669A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano
BR112019025028A2 (pt) Método para preparar um composto.
BR112017023820A2 (pt) ?uso de pelo menos um composto, método de recuperação de pelo menos uma terra rara e composto da fórmula específica?
BR112017008521A2 (pt) processo para fabricar um ou mais composto(s) benzoxazina, processo de síntese, e, composições de produto da reação e de resina curável.
BR112018002156A2 (pt) processo para preparar um composto
ECSP11011346A (es) 3-Amino-2-mercaptoquinolina sustituida como modulador de KCNQ2/3
WO2016089758A3 (en) Organo-1-oxa-4-azonium cyclohexane compounds
MX2018005046A (es) Metodo para producir flutemetamol.
IN2015DN02424A (pt)
MX2010006529A (es) Proceso para recuperar florfenicol de composiciones farmaceuticas.
BR112015018222A2 (pt) método para produzir um composto tricíclico, e composto tricíclico que pode ser produzido pelo referido método de produção
ES2571043T3 (es) Preparación de dihidropiridinas
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 277/66

Ipc: C07D 277/66 (2006.01), A61P 25/28 (2006.01)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/10/2016, OBSERVADAS AS CONDICOES LEGAIS